Found: 43
Select item for more details and to access through your institution.
Familial hypercholesterolemia: potential diagnostic value of mutation screening in a pediatric population of South Africa.
- Published in:
- Clinical Genetics, 1998, v. 54, n. 1, p. 74, doi. 10.1111/j.1399-0004.1998.tb03698.x
- By:
- Publication type:
- Article
CpG hotspot mutations at the LDL receptor locus are a frequent cause of familial hypercholesterolemia among South African Indians.
- Published in:
- Clinical Genetics, 1997, v. 51, n. 6, p. 394, doi. 10.1111/j.1399-0004.1997.tb02497.x
- By:
- Publication type:
- Article
Increases in statin eligibility to reduce cardiovascular risk according to the 2013 ACC/AHA cholesterol guidelines in the Africa Middle East region: a sub-analysis of the Africa Middle East Cardiovascular Epidemiological (ACE) study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Long-term safety and efficacy of alirocumab in South African patients with heterozygous familial hypercholesterolaemia: the ODYSSEY Open-Label Extension study.
- Published in:
- Cardiovascular Journal of Africa, 2019, v. 30, n. 5, p. 279, doi. 10.5830/CVJA-2019-039
- By:
- Publication type:
- Article
Prevalence of dyslipidaemia in statin-treated patients in South Africa: results of the Dyslipidaemia International Study (DYSIS).
- Published in:
- Cardiovascular Journal of Africa, 2013, v. 24, n. 8, p. 330, doi. 10.5830/CVJA-2013-071
- By:
- Publication type:
- Article
Different lipid profiles according to ethnicity in the Heart of Soweto study cohort of de novo presentations of heart disease.
- Published in:
- Cardiovascular Journal of Africa, 2012, v. 23, n. 7, p. 389, doi. 10.5830/CVJA-2012-036
- By:
- Publication type:
- Article
Inclisiran in individuals with diabetes or obesity: Post hoc pooled analyses of the ORION‐9, ORION‐10 and ORION‐11 Phase 3 randomized trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 8, p. 3223, doi. 10.1111/dom.15650
- By:
- Publication type:
- Article
Cardiovascular Risk Factor Burden in Africa and the Middle East: The Africa Middle East Cardiovascular Epidemiological (ACE) Study.
- Published in:
- PLoS ONE, 2014, v. 9, n. 8, p. 1, doi. 10.1371/journal.pone.0102830
- By:
- Publication type:
- Article
2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance.
- Published in:
- European Heart Journal, 2023, v. 44, n. 25, p. 2277, doi. 10.1093/eurheartj/ehad197
- By:
- Publication type:
- Article
Inclisiran and cardiovascular events: a patient-level analysis of phase III trials.
- Published in:
- European Heart Journal, 2023, v. 44, n. 2, p. 129, doi. 10.1093/eurheartj/ehac594
- By:
- Publication type:
- Article
Effect of inclisiran on lipids in primary prevention: the ORION-11 trial.
- Published in:
- European Heart Journal, 2022, v. 43, n. 48, p. 5047, doi. 10.1093/eurheartj/ehac615
- By:
- Publication type:
- Article
ANGPTL3 as a Drug Target in Hyperlipidemia and Atherosclerosis.
- Published in:
- Current Atherosclerosis Reports, 2022, v. 24, n. 12, p. 959, doi. 10.1007/s11883-022-01071-1
- By:
- Publication type:
- Article
Lomitapide and Mipomersen—Inhibiting Microsomal Triglyceride Transfer Protein (MTP) and apoB100 Synthesis.
- Published in:
- Current Atherosclerosis Reports, 2019, v. 21, n. 12, p. 1, doi. 10.1007/s11883-019-0809-3
- By:
- Publication type:
- Article
Atherosclerotic plaque regression in homozygous familial hypercholesterolaemia: a case report of a long-term lipid-lowering therapy involving LDL-receptor-independent mechanisms.
- Published in:
- European Heart Journal Case Reports, 2023, v. 7, n. 1, p. 1, doi. 10.1093/ehjcr/ytad029
- By:
- Publication type:
- Article
The Hurdle of Access to Emerging Therapies and Potential Solutions in the Management of Dyslipidemias.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 14, p. 4160, doi. 10.3390/jcm13144160
- By:
- Publication type:
- Article
Targeting PCSK9 and Beyond for the Management of Low-Density Lipoprotein Cholesterol.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 15, p. 5082, doi. 10.3390/jcm12155082
- By:
- Publication type:
- Article
Homozigot ailevi hiperkolesterolemi: klinisyenlerin tanıyı ve klinik yönetimi geliştirmelerine yönelik yeni anlayışlar ve rehberlik. Avrupa Ateroskleroz Derneği’nin Ailevi Hiperkolesterolemi Üzerine Uzlaşı Paneli yazılı görüşü
- Published in:
- Archives of the Turkish Society of Cardiology / Türk Kardiyoloji Derneği Arşivi, 2015, v. 43, p. 1
- By:
- Publication type:
- Article
Correction: Genetic associations between serum low LDL-cholesterol levels and variants in LDLR, APOB, PCSK9 and LDLRAP1 in African populations.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Leptin, Adiponectin, and High-Sensitivity C-Reactive Protein in Relation to the Metabolic Syndrome in Urban South African Blacks With and Without Coronary Artery Disease.
- Published in:
- Metabolic Syndrome & Related Disorders, 2009, v. 7, n. 3, p. 243, doi. 10.1089/met.2008.0080
- By:
- Publication type:
- Article
Pathogenesis and Management of the Dyslipidemia of the Metabolic Syndrome.
- Published in:
- Metabolic Syndrome & Related Disorders, 2009, v. 7, n. 2, p. 83, doi. 10.1089/met.2008.0079
- By:
- Publication type:
- Article
Genetic associations between serum low LDL-cholesterol levels and variants in LDLR, APOB, PCSK9 and LDLRAP1 in African populations.
- Published in:
- PLoS ONE, 2020, v. 15, n. 2, p. 1, doi. 10.1371/journal.pone.0229098
- By:
- Publication type:
- Article
Inclisiran administration potently and durably lowers LDL-C over an extended-term follow-up: the ORION-8 trial.
- Published in:
- Cardiovascular Research, 2024, v. 120, n. 12, p. 1400, doi. 10.1093/cvr/cvae109
- By:
- Publication type:
- Article
Relationship between plasma insulin and blood pressure in South African black women in Johannesburg.
- Published in:
- 1992
- By:
- Publication type:
- journal article
Insulin-receptor activity in nondiabetic and diabetic urbanized South African black women.
- Published in:
- 1992
- By:
- Publication type:
- journal article
Severe Hypophosphatemia: The Hidden Truth.
- Published in:
- Clinical Chemistry, 2023, v. 69, n. 5, p. 450, doi. 10.1093/clinchem/hvad028
- By:
- Publication type:
- Article
Cryptogenic Cushing Syndrome Due to a White Lie.
- Published in:
- Clinical Chemistry, 2020, v. 66, n. 5, p. 658, doi. 10.1093/clinchem/hvaa035
- By:
- Publication type:
- Article
The Effects of Mipomersen on Inhibiting Hepatic VLDL Apolipoprotein B100 Synthesis and Propensity for Hepatic Steatosis.
- Published in:
- Clinical Chemistry, 2016, v. 62, n. 8, p. 1052, doi. 10.1373/clinchem.2016.255794
- By:
- Publication type:
- Article
Evolocumab in paediatric heterozygous familial hypercholesterolaemia: cognitive function during 80 weeks of open-label extension treatment.
- Published in:
- European Journal of Preventive Cardiology, 2024, v. 31, n. 3, p. 302, doi. 10.1093/eurjpc/zwad332
- By:
- Publication type:
- Article
Modelling the potential long-term survival benefit of evinacumab treatment vs. standard of care in patients with homozygous familial hypercholesterolaemia.
- Published in:
- European Journal of Preventive Cardiology, 2023, v. 30, n. 17, p. 1874, doi. 10.1093/eurjpc/zwad203
- By:
- Publication type:
- Article
Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation.
- Published in:
- European Journal of Preventive Cardiology, 2015, v. 22, n. 7, p. 849, doi. 10.1177/2047487314533218
- By:
- Publication type:
- Article
Demographic and Clinical Factors Associated with Development of Type 2 Diabetes: A Review of the Literature.
- Published in:
- International Journal of General Medicine, 2020, v. 13, p. 121, doi. 10.2147/IJGM.S226010
- By:
- Publication type:
- Article
Consistent LDL‐C response with evolocumab among patient subgroups in PROFICIO: A pooled analysis of 3146 patients from phase 3 studies.
- Published in:
- Clinical Cardiology, 2018, v. 41, n. 10, p. 1328, doi. 10.1002/clc.23049
- By:
- Publication type:
- Article
A "STEP" in the right direction - Metabolic surgery versus medical therapy for obesity.
- Published in:
- South African Gastroenterology Review, 2021, v. 19, n. 3, p. 13
- By:
- Publication type:
- Article
Efficacy and Safety of Inclisiran in Patients with Polyvascular Disease: Pooled, Post Hoc Analysis of the ORION-9, ORION-10, and ORION-11 Phase 3 Randomized Controlled Trials.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 493, doi. 10.1007/s10557-022-07413-0
- By:
- Publication type:
- Article
Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia.
- Published in:
- Cardiovascular Drugs & Therapy, 2019, v. 33, n. 1, p. 69, doi. 10.1007/s10557-019-06852-6
- By:
- Publication type:
- Article
Poor cardiovascular health is associated with subclinical atherosclerosis in apparently healthy sub-Saharan African populations: an H3Africa AWI-Gen study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Survival in homozygous familial hypercholesterolaemia is determined by the on-treatment level of serumcholesterol.
- Published in:
- European Heart Journal, 2018, v. 39, n. 14, p. 1162, doi. 10.1093/eurheartj/ehx317
- By:
- Publication type:
- Article
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.
- Published in:
- European Heart Journal, 2017, v. 38, n. 32, p. 2459, doi. 10.1093/eurheartj/ehx144
- By:
- Publication type:
- Article
Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management.
- Published in:
- European Heart Journal, 2015, v. 36, n. 17, p. 1012, doi. 10.1093/eurheartj/ehv043
- By:
- Publication type:
- Article
Efficacy and safety of evolocumab (AMG 145), a fully human monoclonal antibody to PCSK9, in hyperlipidaemic patients on various background lipid therapies: pooled analysis of 1359 patients in four phase 2 trials.
- Published in:
- European Heart Journal, 2014, v. 35, n. 33, p. 2249
- By:
- Publication type:
- Article
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society.
- Published in:
- European Heart Journal, 2014, v. 35, n. 32, p. 2146
- By:
- Publication type:
- Article
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease.
- Published in:
- European Heart Journal, 2013, v. 34, n. 45, p. 3478
- By:
- Publication type:
- Article
Two novel and two known low-density lipoprotein receptor gene mutations in German patients with familial hypercholesterolemia.
- Published in:
- Human Mutation, 1998, v. 11, p. S232, doi. 10.1002/humu.1380110174
- By:
- Publication type:
- Article